What is C E Bradley Laboratories?
Established in 1939, C E Bradley Laboratories operates as a premier manufacturer of high-performance coatings, including stains, lacquers, enamels, and advanced UV-curable solutions. The company distinguishes itself through a combination of legacy manufacturing excellence and modern technical support, offering bespoke color matching and application guidance to a diverse B2B client base. By maintaining a robust presence in the industrial sector for over eight decades, the organization has cultivated a reputation for reliability and precision in material science. Their facility, situated within a strategic industrial park, serves as the hub for both production and research, enabling the company to address the evolving demands of the graphic arts and industrial manufacturing markets effectively.
How much funding has C E Bradley Laboratories raised?
C E Bradley Laboratories has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in C E Bradley Laboratories
PPP
Public-Private Partnership
What's next for C E Bradley Laboratories?
The recent infusion of capital is expected to catalyze the company's long-term growth trajectory, specifically targeting infrastructure upgrades and capacity expansion. As the firm transitions into this next phase of development, management is likely to prioritize the scaling of its UV coating production lines to meet the rising demand for sustainable and high-durability finishes. Furthermore, the strategic allocation of these funds will likely support the integration of enhanced technical assistance capabilities, ensuring that C E Bradley Laboratories remains at the forefront of the surface coating industry. By optimizing its operational footprint, the company aims to solidify its competitive advantage and drive sustained value for its stakeholders in the coming fiscal periods.
See full C E Bradley Laboratories company page
